Labosys Instruments India Pvt Ltd

Closing FY 2025–2026 with Gratitude & Growth 🚀

As we mark the close of this financial year, I take a moment to reflect on what has been a truly transformative journey for Labosys Instruments India Pvt. Ltd.

First and foremost, our sincere thanks to our valued customers for their continued trust and partnership—you are the foundation of everything we do.

We extend our deep gratitude to our esteemed principal partners:
Thermo Fisher Scientific | Molecular Devices | Sartorius | Beckman Coulter | Bruker
Your support has been instrumental in enabling us to deliver excellence across markets.

A big thank you to our internal teams—Sales, Service, Product Management, Administration, and Logistics—for your relentless ex*****on and commitment. Also, heartfelt appreciation to our investors for believing in our vision and supporting our growth trajectory.

📈 Key Highlights of FY 2025–2026:
• Successfully expanded operations into Tamil Nadu
• Doubled our sales & service revenue compared to last year
• Onboarded new strategic partnerships with Sartorius & Bruker
• Conducted 2+ roadshows every month, strengthening market presence
• Increased team strength to 30+ employees, with focused expansion into Tier-2 cities
• Introduced employee-first initiatives: EPF, Insurance, company assets & benefits
• Expanded infrastructure:
• Office space scaled from 1500 sq.ft to 3000 sq.ft
• Strengthened operations with digital transformation:
• Implementation of ERP, CRM, and Service Tracking systems
• Improved handling of AMC, installations, and service contracts

This year has been about scaling with structure, growing with purpose, and building with people at the center.

As we step into the new financial year, we remain committed to driving innovation, strengthening partnerships, and delivering impactful solutions across the life sciences ecosystem.

Thank you once again to everyone who has been part of this journey. The best is yet to come.

We are pleased to share that Labosys Instruments India Pvt. Ltd. actively participated in the 1st Hematopathology CME – Outline of Diagnostic Tools in Hemato-Oncology held on January 10, 2026, at Homi Bhabha Cancer Hospital & Research Centre, Visakhapatnam.

It was a valuable platform to engage with clinicians, pathologists, and researchers, and to contribute to discussions on advancing diagnostic capabilities in hemato-oncology. We are honored to receive recognition for our participation and support.

Our sincere thanks to the organizing committee and faculty for a well-structured and impactful academic program.
We also acknowledge our principals Molecular Devices Thermo Fisher Scientifics Beckman Coulter Life Sciences and Applied Biosystems for their continued collaboration in delivering innovative diagnostic solutions.

At Labosys, we remain committed to enabling clinical excellence through trusted technologies, partnerships, and knowledge exchange.


Molecular Devices India Danaher Corporation Thermo Fisher Scientific Bruker

Labosys Instruments is pleased to welcome Mr. Siva Prakash as Chairman & Executive Director.
His leadership will further strengthen our governance and guide Labosys into its next phase of growth and scale.
We look forward to a strong and impactful association.